Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Cancer remains a significant risk to human health. Nanomedicine is a new multidisciplinary
field that is garnering a lot of interest and investigation. Nanomedicine shows great potential …
field that is garnering a lot of interest and investigation. Nanomedicine shows great potential …
Non-small-cell lung cancer
Non-small-cell lung cancer (NSCLC) is one of the most frequent cancer types and is
responsible for the majority of cancer-related deaths worldwide. The management of …
responsible for the majority of cancer-related deaths worldwide. The management of …
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic …
AR Lyon, T López-Fernández, LS Couch… - European Heart …, 2022 - academic.oup.com
ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …
that, unless otherwise provided for by national regulations, offlabel use of medication should …
Postoperative radiotherapy versus no postoperative radiotherapy in patients with completely resected non-small-cell lung cancer and proven mediastinal N2 …
C Le Pechoux, N Pourel, F Barlesi, D Lerouge… - The lancet …, 2022 - thelancet.com
Background In patients with non-small-cell lung cancer (NSCLC), the use of postoperative
radiotherapy (PORT) has been controversial since 1998, because of one meta-analysis …
radiotherapy (PORT) has been controversial since 1998, because of one meta-analysis …
[HTML][HTML] Immune checkpoint inhibitors in non-small cell lung cancer: progress, challenges, and prospects
S Tang, C Qin, H Hu, T Liu, Y He, H Guo, H Yan… - Cells, 2022 - mdpi.com
Non-small cell lung cancer is one of the most common types of malignances worldwide and
the main cause of cancer-related deaths. Current treatment for NSCLC is based on surgical …
the main cause of cancer-related deaths. Current treatment for NSCLC is based on surgical …
[HTML][HTML] Demystifying the results of RTOG 0617: identification of dose sensitive cardiac subregions associated with overall survival
Introduction The RTOG 0617 trial presented a worse survival for patients with lung cancer
treated in the high-dose (74 Gy) arm. In multivariable models, radiation level and whole …
treated in the high-dose (74 Gy) arm. In multivariable models, radiation level and whole …
Association of sinoatrial node radiation dose with atrial fibrillation and mortality in patients with lung cancer
Importance Atrial fibrillation (AF) can develop following thoracic irradiation. However, the
critical cardiac substructure responsible for AF has not been properly studied. Objective To …
critical cardiac substructure responsible for AF has not been properly studied. Objective To …
Mitochondrial dysfunction at the crossroad of cardiovascular diseases and cancer
A large body of evidence indicates the existence of a complex pathophysiological
relationship between cardiovascular diseases and cancer. Mitochondria are crucial …
relationship between cardiovascular diseases and cancer. Mitochondria are crucial …
Radiation treatment mechanisms of cardiotoxicity: a systematic review
KC Siaravas, CS Katsouras, C Sioka - International Journal of Molecular …, 2023 - mdpi.com
Radiotherapy may be used alone or in combination with chemotherapy for cancer treatment.
There are many mechanisms of radiation treatment exposure to toxicities. Our aim was to …
There are many mechanisms of radiation treatment exposure to toxicities. Our aim was to …
The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: staging and multidisciplinary management of patients with early-stage non …
The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document:
Staging and multidisciplinary management of patients with early-stage non–small cell lung …
Staging and multidisciplinary management of patients with early-stage non–small cell lung …